Adani Ports and Special Economic Zone Limited NSE Symbol: ADANIPORTS, BSE Script Code: 532921, would like to inform you that that the company has levied 125 Crores (Rupees One Hundred Twenty Five Crores only) by alloting 1250 rated, listed, Secured, Reedemable, Non- convertible Debentures (NCDs) at the face value of Rs. 10,00,000 each made on private placement basis. It is decided that the Finance meeting will be started at 10:30 A.M and would end at 11:15 A.M.
Taking all necessary preventive measures against COVID-19, all amusement park of the company are going to stay close till 31st March 2020. The decision is adopted by the company with regard to the rules and regulations stated by the government in order to check the spread of COVID -19.
Axis Mutual Fund, NSE Symbol: AXISNIFTY, the Investment Manager of Axis Mutual Fund, Axis Asset Management Company Limited (“Axis AMC”) incorporated in India under the companies Act, 1956. Axis Mutual Fund is registered with the Securities and Exchange Board of India (“SEBI”) under SEBI Regulations, 1996 vide registration number MF/061/09/02. There are 4 types of series in Axis Mutual Fund. In series 1 we can find Axis Capital Builder Fund and Axis Emerging Opportunities Fund while in series 2 we can also find Axis Emerging Opportunities Fund.
IDFC First Bank Limited: NSE Symbol:IDFCFIRSTB: BSE Script Code:539437, has acknowledged of receiving an intimation from Mr. V. Vaidyanathan, Managing Director and Chief Executive Officer of the Bank that he has sold shares worth 2,75,58,412 on 19th March 2020 at about Rs. 58 crores in order to close ESOP loan taken by him. He expects to sell about Rs. 35 crores on 20.03.2020 to repay the extra loan taken by him for ESOP shares and to free his pledged shares. He also claimed that with this sale he will be free from all loan taken from ESOP and no need to sell any more shares in future.
Godrej Properties Limited, NSE Symbol: GODREJPROP; BSE Script Code: 533150; one of the major real estate developers Godrej Properties Limited (GPL) has announced the news of its first entry as a residential plotted developer in Faridabad market . Almost 43.61 acres (17.65 hectares) of land has been bought by BPTP for this purpose. This project will provide around 95,000 square meters (1 million sq. ft.) of plotted development potential contributing to bigger and better plot size along with excellent lifestyle facilities.
Dr. Reddy's Laboratories Limited NSE Symbol: DRREDDY, BSE Script Code:500124, together with its subsidiaries also known as Dr Reddy’s has announced the launch of Pyrimethamine Tablets USP, 25 mg, a therapeutic equivalent. The first wave generic version of Daraprim (Pyrimethamine) Tablets has received approval from the U.S. Food and Drug Adminastration (USFDA) with only AB rated generic version Daraprim (Pyrimethamine) Tablets. It is used for the treatment of toxoplasmosis when applied together with Sulfonamide.
Jindal Stainless (Hisar) Limited, NSE Symbol: JSLHISAR; BSE Script Code: 539597, according to some latest news promoters who have pledged their maximum shareholding as margin or primary security are at threat of losing control over their companies. The leading institutions are determined to pledge and sell off the shares when the share price falls down. Jindal Stainless (Hisar) Limited (JSHL/Company) is one of those companies whose name is included in this list.
Dr. Reddy’s Laboratories Limited, NSE Symbol: DRREDDY; BSE Script Code: 500124, together with its subsidiaries also known as Dr Reddy’s has announced the launch of Naloxone Hydrochloride injection, USP 2 mg/ 2 mL (1 mg/mL) Single-dose Prefilled Syringe, a therapeutic equivalent generic version of Narcan (naloxone hydrochloride) injection USP, approved by the U.S. Food and Drug Administration (USFDA). Thus. Nalaxone Hydrochloride could be also availed in 2 mL single dose prefilled syringe. The Chief Executive Officer of Dr.
KEC International Ltd, NSE Symbol KEC, BSE Script Code 532714, a global infrastructure EPC major & RPG group company has received four new orders worth Rs. 1047 crores across its different businesses.
The company has secured following orders:
Training and Development Business and SAE Towers, a subsidiary of the company have received orders worth Rs. 669 crores for Training and development projects in India, South Asian Association for Regional Cooperation (SAARC), Middle East and the Americas.
Dr. Reddy's Laboratories Limited NSE Symbol DRREDDY, BSE Script Code:500124, together with its subsidiaries also known as Dr. Reddy’s has announced the launch of Ziprasidone Mesylate for injection, 20 mg (base) / mL Single-dose Vials, the therapeutic generic equivalent of Geodon (Ziprasidone mesylate) Injection, 20 mg/ mL, approved by the U.S Food and Drug Administration (USFDA).